REGISTERED
on 04 Oct 2022
Last Applicant/ Owned by
9880 Campus Point Drive, Suite 370
San Diego
CA
92121
Serial Number
90009679 filed on 18th Jun 2020
Registration Number
6866932 registered on 04th Oct 2022
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
AUTOBAHN
Pharmaceutical preparations for treating central nervous system (CNS) disorders; therapeutic agents for treating central nervous system (CNS) disorders; thyromimetic pharmaceutical preparations for treating central nervous system (CNS) disorders; thyromimetic therapeutic agents for treating central nervous system (CNS) disorders
Classification Information
Class [005]
Pharmaceutical Products
Pharmaceutical preparations for treating central nervous system (CNS) disorders; therapeutic agents for treating central nervous system (CNS) disorders; thyromimetic pharmaceutical preparations for treating central nervous system (CNS) disorders; thyromimetic therapeutic agents for treating central nervous system (CNS) disorders
First Use Date in General
06th Dec 2021
First Use Date in Commerce
06th Dec 2021
Mark Details
Serial Number
No 90009679
Mark Type
No Service/Collective Mark
Attorney Docket Number
No 60179-TM1003
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.01.21 -
Circles that are totally or partially shaded
26.13.14 -
Three or more quadrilaterals
26.13.21 -
Quadrilaterals that are completely or partially shaded
27.03.01 -
Geometric figures forming letters or numerals, including punctuation
Legal History
| Status Date | Action Taken |
|---|---|
| 04th Oct 2022 | REGISTERED-PRINCIPAL REGISTER |
| 04th Oct 2022 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| 30th Aug 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 29th Aug 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 25th Aug 2022 | ASSIGNED TO LIE |
| 25th Aug 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 25th Aug 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 29th Jul 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 15th Feb 2022 | ASSIGNED TO EXAMINER |
| 15th Feb 2022 | SU - NON-FINAL ACTION - WRITTEN |